133
Participants
Start Date
October 5, 2015
Primary Completion Date
October 24, 2019
Study Completion Date
October 24, 2019
Camidanlumab tesirine
Intravenous (IV) infusion.
Memorial Sloan-Kettering Cancer Center, New York
Virginia Cancer Specialists, PC, Fairfax
University Hospitals Cleveland Medical Center, Cleveland
Froedtert Hospital/Medical College of Wisconsin, Milwaukee
Cancer Therapy and Research Center at The University of Texas Health Science Center at San Antonio, San Antonio
City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
The University of Texas/MD Anderson Cancer Center, Houston
Guy's and St. Thomas' Hospital NHS Trust, London
The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne
Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, Southampton
Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford
The Christie NHS Foundation Trust, Manchester
Lead Sponsor
ADC Therapeutics S.A.
INDUSTRY